Targeted Therapy and Mechanism of Drug Resistance in Non-small Cell Lung Cancer 
with Epidermal Growth Factor Receptor Gene Mutation

Targeted Therapy and Mechanism of Drug Resistance in Non-small Cell Lung Cancer 
with Epidermal Growth Factor Receptor Gene Mutation

Lung cancer is the sixth leading cause of death worldwide and one of the leading cause of death from malignant tumors. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epidermal growth factor receptor (EGFR) gene mutation is a common mutation in NSCLC. For advanced NSCLC pa...

Full description

Bibliographic Details
Main Authors: Junxia HUANG, Hong WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
targeted therapy
epidermal growth factor receptor
tyrosine kinase inhibitors
drug resistance
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.05

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.05

Similar Items